After 6 months of preparatory work and the finalization of Lyxor acquisition, Amundi confirms the strategic and industrial benefits of this project, and presents new ambitions and the organization for two key areas of expertise: passive management and liquid alternative investment.
Founded in 1998, Lyxor totalizes more than €140bn1,2 in Assets under Management and advisory (AuM). Lyxor is one of the key players in the ETF market (€95bn1 of AuM, 3rd largest player in Europe with a 7.7% market share) and has developed a recognized expertise in active management (€45 bn of AuM1), in particular through its leading alternative platform.
Thanks to this acquisition, Amundi benefits from strong levers to accelerate its development and announce two new strong ambitions:
Accelerate in passive management with a target of 50% AuM growth by 2025 The acquisition of Lyxor - the European pioneer of ETFs - propels Amundi Passive platform (ETFs, Index & Smart Beta solutions) to the position of European leading ETF provider3. Collectively the combined ETF business represents over €170bn in assets under management1, resulting in a UCITS ETF market share of 14% for Amundi.
Expand our leadership position in liquid alternatives with the creation of the Amundi Alternatives business line
The integration of Lyxor allows Amundi to enrich its active management capabilities with the addition of an alternative investment expertise, giving investors access to innovative sources of diversification and performance for their portfolios. Amundi affirms its position as a leader in alternative investment, with the objective of increasing the Alternative UCITS platform by 50% by 2025 and accelerating the development of DMAP towards institutional clients internationally.
1Source : Amundi, as of 30 September 2021 2Excluding advisory mandates not included in AuM according to Amundi's methodology ; Activities from Lyxor retained by Société Générale: structured asset management and other activities dedicated to private banking 3Source : Amundi, Lyxor, ETFGI, as of September 2021